Avyxa Pharma LLC – Trademark Portfolio
Entity Type: 16
Avyxa Pharma LLC holds 31 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 29 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 10 trademarks are registered and 19 are pending. Notable registered marks include A, AVYXA, AXTLE, KYXATA, and AVGEMSI. The owner is based in Parsippany, NJ.
1 Upper Pond Rd, Building E 4th Floor
Parsippany, NJ 07054
Showing of trademarks Trademarks
Trademark Classifications
Avyxa Pharma LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Avyxa Pharma LLC have?
Avyxa Pharma LLC has 31 U.S. trademarks filed with the USPTO. Of these, 10 registered, 19 pending, 2 abandoned.
What trademark classes does Avyxa Pharma LLC file in?
Avyxa Pharma LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Avyxa Pharma LLC's most well-known trademarks?
Avyxa Pharma LLC's registered trademark portfolio includes well-known marks such as A, AVYXA, AXTLE, KYXATA, and AVGEMSI. These are among 10 currently registered trademarks in the portfolio.
What is Avyxa Pharma LLC's trademark registration success rate?
Avyxa Pharma LLC has a 83% trademark registration rate, with 10 out of 12 resolved applications resulting in successful registration. Currently, 19 applications are pending review.